Clinical Cardiology

View the latest content related to this topic

ACC 2018

ODYSSEY Delivers a Win for Alirocumab in ACS, With a Signal of Survival Benefit

All eyes were on the 15% relative reduction in the risk of all-cause mortality with the PCSK9 inhibitor, a benefit not seen with evolocumab in FOURIER

Michael O'Riordan

March 10, 2018

Slides

See all

Presentation

ACC 2018

CANTOS: Anti-Inflammatory Therapy with Canakinumab for the Prevention and Management of Diabetes

Presenter: Brendan M. Everett

March 12, 2018

Presentation

ACC 2018

The PHARMCLO Study: A Prospective, Randomised, Multicentre Study of a Pharmacogenomic Approach to the Selection of Antiplatelet Therapy in Acute Coronary Syndromes

Presenter: Diego Ardissino

March 12, 2018

Presentation

ACC 2018

Comparison of Effectiveness, Safety, and The Net Clinical Outcome Between Different Direct Oral Anticoagulants

Presenter: Steve Deitelzweig

March 12, 2018

Presentation

ACC 2018

Results of the SWAP (Switching Antiplatelet Therapy) - 4 Study

Presenter: Francesco Franchi

March 11, 2018

Presentation

ACC 2018

Uptake and Utilization of Drug-Eluting Bioresorbable Vascular Scaffolds: A CathPCI Registry Study

Presenter: Ajay J. Kirtane

March 11, 2018

News

See all

News

The Higher the LDL, the Bigger the Mortality Benefit of Intensive Therapy: Meta-analysis

By Michael O'Riordan

April 20, 2018

News

Repeat BP Measurements in the Office Are Key, Study Highlights

By Todd Neale

April 19, 2018

News

Number of Cigarettes Smoked per Day Influences Stroke Risk in Young Men

By L.A. McKeown

April 19, 2018

News

Value of Ambulatory BP Monitoring Bolstered by Large Study

By Todd Neale

April 18, 2018

News • Interventional

New Biomarker on the Block, FGF-23, May Aid in Secondary-Event Prediction Following ACS

By Yael L. Maxwell

April 18, 2018

CRT 2018

March 3

March 06, 2018

CTO 2018

February 15

February 16, 2018

Videos on This Topic

See all

Interview

ACC 2018: Dr. Paul Ridker and Dr. C. Michael Gibson Discuss CANTOS

March 11, 2018

Advertisement

Clinical Cardiology

ODYSSEY Delivers a Win for Alirocumab in ACS, With a Signal of Survival Benefit

Slides

CANTOS: Anti-Inflammatory Therapy with Canakinumab for the Prevention and Management of Diabetes

The PHARMCLO Study: A Prospective, Randomised, Multicentre Study of a Pharmacogenomic Approach to the Selection of Antiplatelet Therapy in Acute Coronary Syndromes

Comparison of Effectiveness, Safety, and The Net Clinical Outcome Between Different Direct Oral Anticoagulants

Results of the SWAP (Switching Antiplatelet Therapy) - 4 Study

Uptake and Utilization of Drug-Eluting Bioresorbable Vascular Scaffolds: A CathPCI Registry Study

News

The Higher the LDL, the Bigger the Mortality Benefit of Intensive Therapy: Meta-analysis

Repeat BP Measurements in the Office Are Key, Study Highlights

Number of Cigarettes Smoked per Day Influences Stroke Risk in Young Men

Value of Ambulatory BP Monitoring Bolstered by Large Study

New Biomarker on the Block, FGF-23, May Aid in Secondary-Event Prediction Following ACS

More on This Topic

Upcoming Conferences

TCT 2018

Conference Coverage

CRT 2018

CTO 2018

Videos on This Topic

ACC 2018: Dr. Paul Ridker and Dr. C. Michael Gibson Discuss CANTOS

Advertisement

Advertisement

Clinical Cardiology

Slides

News

More on This Topic

Upcoming Conferences

Conference Coverage

Videos on This Topic

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content

Nominate A Fellow